Whole Genome Sequencing and Metabolomic Study of Cave Streptomyces Isolates ICC1 and ICC4
- PMID: 31134037
- PMCID: PMC6524458
- DOI: 10.3389/fmicb.2019.01020
Whole Genome Sequencing and Metabolomic Study of Cave Streptomyces Isolates ICC1 and ICC4
Abstract
The terrestrial subsurface microbiome has gained considerable amount of interests in the recent years because of its rich potential resource for biomining novel genes coding for metabolites possessing antimicrobial activities. In our previous study, we identified two Streptomyces isolates, designated as ICC1 and ICC4, from the Iron Curtain Cave, Chilliwack, Canada that exhibited antagonistic activities against the multidrug resistant strains of Escherichia coli. In this study, the genomes of these two isolates were sequenced by Illumina MiSeq, assembled and annotated. The genes associated with secondary metabolite production were identified and annotated using the bioinformatics platforms antiSMASH and BAGEL. ICC1 and ICC4 were then cultivated and ICC1 metabolome characterized by UHPLC-ESI-HRMS. The Global Natural Products Social Molecular Networking was used to identify metabolites based on the MS/MS spectral data. ICC1 and ICC4 showed a high level of sequence identity with the terrestrial bacteria Streptomyces lavendulae; however, they possess a greater secondary metabolite potential as estimated by the total number of identified biosynthetic gene clusters (BGCs). In particular, ICC1 and ICC4 had a greater number of polyketide and non-ribosomal peptide BGCs. The most frequently detected BGCs were those predicted to generate terpenes, small and low complexity dipeptides and lipids. Spectral analysis clearly identified a number of diketopiperazine products through matched reference spectra for cyclo (Leu-Pro), cyclo (Pro-Val) and cyclo [(4-hydroxyPro)-Leu]. One of the terpenes gene clusters predicted by antiSMASH possesses a seven-gene pathway consistent with diazepinomicin biosynthesis. This molecule contains a very rare core structure and its BGC, to date, has only been identified from a single bacterial genome. The tetrapeptide siderophore coelichelin BGC was unambiguously identified in the genome, however, the metabolite could not be identified from the culture extracts. Two type III polyketides, 2', 5' - dimethoxyflavone and nordentatin, were identified from the UHPLC-HRMS data of the aqueous and n-butanolic fractions of Streptomyces sp. ICC1, respectively. A BGC likely encoding these metabolites was predicted in both genomes. The predicted similarities in molecule production and genome shared by these two strains could be an indicative of a cooperative mode of living in extreme habitats instead of a competitive one. This secondary metabolite potential may contribute to the fitness of ICC1 and ICC4 in the Iron Curtain Cave.
Keywords: Streptomyces; genome; metabolome; secondary metabolites; whole genome sequencing.
Figures






Similar articles
-
Comparative Genomics Reveals a Remarkable Biosynthetic Potential of the Streptomyces Phylogenetic Lineage Associated with Rugose-Ornamented Spores.mSystems. 2021 Aug 31;6(4):e0048921. doi: 10.1128/mSystems.00489-21. Epub 2021 Aug 24. mSystems. 2021. PMID: 34427515 Free PMC article.
-
Biosynthetic gene cluster signature profiles of pathogenic Gram-negative bacteria isolated from Egyptian clinical settings.Microbiol Spectr. 2023 Sep 14;11(5):e0134423. doi: 10.1128/spectrum.01344-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37707241 Free PMC article.
-
Ecology shapes the genomic and biosynthetic diversification of Streptomyces bacteria from insectivorous bats.Microb Genom. 2024 Apr;10(4):001238. doi: 10.1099/mgen.0.001238. Microb Genom. 2024. PMID: 38625724 Free PMC article.
-
Synthetic Biology Tools for Novel Secondary Metabolite Discovery in Streptomyces.J Microbiol Biotechnol. 2019 May 28;29(5):667-686. doi: 10.4014/jmb.1904.04015. J Microbiol Biotechnol. 2019. PMID: 31091862 Review.
-
Cloning and Heterologous Expression of a Large-sized Natural Product Biosynthetic Gene Cluster in Streptomyces Species.Front Microbiol. 2017 Mar 15;8:394. doi: 10.3389/fmicb.2017.00394. eCollection 2017. Front Microbiol. 2017. PMID: 28360891 Free PMC article. Review.
Cited by
-
Metabologenomics approach to the discovery of novel compounds from Streptomyces sp. GMR22 as anti-SARS-CoV-2 drugs.Heliyon. 2021 Nov;7(11):e08308. doi: 10.1016/j.heliyon.2021.e08308. Epub 2021 Nov 2. Heliyon. 2021. PMID: 34746476 Free PMC article.
-
Streptomyces sp. VITGV156 secondary metabolite binds pathogenic protein PBP2a and Beta-lactamase.Front Bioinform. 2025 Mar 26;5:1544800. doi: 10.3389/fbinf.2025.1544800. eCollection 2025. Front Bioinform. 2025. PMID: 40206635 Free PMC article.
-
Diversity of Polyketide Synthases and Nonribosomal Peptide Synthetases Revealed Through Metagenomic Analysis of a Deep Oligotrophic Cave.Microb Ecol. 2021 Jan;81(1):110-121. doi: 10.1007/s00248-020-01554-1. Epub 2020 Jul 8. Microb Ecol. 2021. PMID: 32638044
-
Applications and Restrictions of Integrated Genomic and Metabolomic Screening: An Accelerator for Drug Discovery from Actinomycetes?Molecules. 2021 Sep 7;26(18):5450. doi: 10.3390/molecules26185450. Molecules. 2021. PMID: 34576921 Free PMC article. Review.
-
Whole genome analysis of Streptomyces sp. RerS4, a Rehmannia glutinosa rhizosphere microbe producing a new lipopeptide.Heliyon. 2023 Aug 28;9(9):e19543. doi: 10.1016/j.heliyon.2023.e19543. eCollection 2023 Sep. Heliyon. 2023. PMID: 37681179 Free PMC article.
References
-
- Abbott J. C., Aanensen D. M., Rutherford K., Butcher S., Spratt B. G. (2005). WebACT—an online companion for the artemis comparison tool. Bioinformatics 21 3665–3666. - PubMed
-
- Andrews S. C., Robinson A. K., Rodríguez-Quiñones F. (2003). Bacterial iron homeostasis. FEMS Microbiol. Rev. 27 215–237. - PubMed
-
- Axenov-Gribanov D. V., Voytsekhovskaya I. V., Tokovenko B. T., Protasov E. S., Gamaiunov S. V., Rebets Y. V., et al. (2016). Actinobacteria isolated from an underground lake and moonmilk speleothem from the biggest conglomeratic karstic cave in siberia as sources of novel biologically active compounds. PLoS One 11:e0149216. 10.1371/journal.pone.0149216 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases